Literature DB >> 10555742

Cells shed from tumours show reduced clonogenicity, resistance to apoptosis, and in vivo tumorigenicity.

M A Swartz1, C A Kristensen, R J Melder, S Roberge, E Calautti, D Fukumura, R K Jain.   

Abstract

The goal of this study was to compare growth characteristics of cells shed from a tumour with the native tumour cells. The human colon adenocarcinoma LS174T and its highly metastatic subline LS LiM 6 were grown as tissue-isolated tumours in nude mice and perfused to collect shed cells. The tumours were then excised and prepared into single-cell suspensions. Clonogenicity in 0.3-0.9% agarose, apoptotic fraction, and in vivo tumorigenicity were determined for each population. In both tumour lines, shed cells were less clonogenic, more apoptotic and less tumorigenic than cells isolated directly from their native tissue. These findings suggest that shed cells have a low metastatic potential compared to native tumour cells, most likely because they represent an apoptotic population.

Entities:  

Mesh:

Year:  1999        PMID: 10555742      PMCID: PMC2374305          DOI: 10.1038/sj.bjc.6690760

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  21 in total

1.  Malignant cells facilitate lung metastasis by bringing their own soil.

Authors:  Dan G Duda; Annique M M J Duyverman; Mitsutomo Kohno; Matija Snuderl; Ernst J A Steller; Dai Fukumura; Rakesh K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

2.  An isolated tumor perfusion model in mice.

Authors:  Annique M M J Duyverman; Mitsutomo Kohno; Sylvie Roberge; Dai Fukumura; Dan G Duda; Rakesh K Jain
Journal:  Nat Protoc       Date:  2012-03-22       Impact factor: 13.491

3.  A novel preclinical method to quantitatively evaluate early-stage metastatic events at the murine blood-brain barrier.

Authors:  Chris E Adkins; Mohamed I Nounou; Rajendar K Mittapalli; Tori B Terrell-Hall; Afroz S Mohammad; Rajaganapathi Jagannathan; Paul R Lockman
Journal:  Cancer Prev Res (Phila)       Date:  2014-10-27

4.  Minimal disease detection in peripheral blood and bone marrow from patients with non-metastatic neuroblastoma.

Authors:  Yania Yáñez; Elena Grau; Silvestre Oltra; Adela Cañete; Francisco Martínez; Carmen Orellana; Rosa Noguera; Sarai Palanca; Victoria Castel
Journal:  J Cancer Res Clin Oncol       Date:  2011-06-25       Impact factor: 4.553

Review 5.  Genetic factors in metastatic progression of cutaneous melanoma: the future role of circulating melanoma cells in prognosis and management.

Authors:  A Ireland; M Millward; R Pearce; M Lee; M Ziman
Journal:  Clin Exp Metastasis       Date:  2011-02-11       Impact factor: 5.150

Review 6.  Lung cancer screening.

Authors:  Mylene T Truong; Reginald F Munden
Journal:  Curr Oncol Rep       Date:  2003-07       Impact factor: 5.075

7.  Lung cancer with gastrointestinal metastasis - review of theories of metastasis with three rare case descriptions.

Authors:  Rohtesh S Mehta; Andrew D Liman; Vida A Passero; Agnes K Liman
Journal:  Cancer Microenviron       Date:  2013-08-21

Review 8.  Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed?

Authors:  Maximilian Bockhorn; Rakesh K Jain; Lance L Munn
Journal:  Lancet Oncol       Date:  2007-05       Impact factor: 41.316

9.  Cancer Cells Resist Mechanical Destruction in Circulation via RhoA/Actomyosin-Dependent Mechano-Adaptation.

Authors:  Devon L Moose; Benjamin L Krog; Tae-Hyung Kim; Lei Zhao; Sophia Williams-Perez; Gretchen Burke; Lillian Rhodes; Marion Vanneste; Patrick Breheny; Mohammed Milhem; Christopher S Stipp; Amy C Rowat; Michael D Henry
Journal:  Cell Rep       Date:  2020-03-17       Impact factor: 9.423

Review 10.  Dissemination from a Solid Tumor: Examining the Multiple Parallel Pathways.

Authors:  Moriah E Katt; Andrew D Wong; Peter C Searson
Journal:  Trends Cancer       Date:  2018-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.